Article
Cystatin C at the Crossroads: Unraveling a Multidimensional Biomarker in Alzheimer’s Disease and Cognitive Decline
2025-11-05
Abstract excerpt
Cystatin C (CysC) is increasingly recognized as a critical biomarker at the interface of neurodegeneration, metabolic health, and vascular pathology. This narrative review synthesizes current evidence on the role of CysC in cognitive impairment and Alzheimer’s disease, leveraging findings from cross-sectional, longitudinal, genetic, and translational studies. CysC levels are modulated by genetic polymorphisms, pat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b07f79bb-b2f7-52aa-8132-9b943093447d
- DOI
- 10.32388/sv51tf
